Gross
W, Holland PV: Water and ionic regulation in a terrestrial hermit crab.
Physiol Zool 1960;33:21-28.
Andrews
JR, Holland PV: Sulfur 35 studies in human chrondosarcoma. Am J Roentgenol
Radium Nucl Med 1965;94:798-806.
Lemmon
WR Jr, Holland PV, Holland JM: The hepatopathy of hypernephroma. Am
J Surg 1965;110:487-491.
Rubinson
RM, Holland PV, Schmidt PJ, Morrow AG: Serum hepatitis after open-heart
operations. J Thorac Cardiovasc Surg 1965; 50:575-581.
Holland
PV, Alter HJ, Schmidt PJ: A data retrieval system for blood donor information.
Transfusion 1965;5:543-549.
Holland
PV, Rubinson RM, Morrow AG, Schmidt PJ: Gamma globulin in the prophylaxis
of posttransfusion hepatitis. JAMA 1966;196:471-474.
Lostumbo
MM, Holland PV, Schmidt PJ: Isoimmunization after multiple transfusions.
N Engl J Med 1966;275:141-144.
Holland
PV, Menken M, Berlin NI: Autoimmune hemolytic anemia, acute leukemia,
and carcinoma of the lung. Arch Intern Med 1967;120:341-344.
Grindon
AJ, Holland PV, Schmidt PJ: Posttransfusion hepatitis. Am Heart J 1967;74:591-594.
Schmidt
PJ, Holland PV: Pathogenesis of the acute renal failure associated with
incompatible transfusion. Lancet II:1967;1169-1172.
Cooke
JV, Holland PV, Schulman NR: Cryoprecipitate concentrates of factor
VIII for surgery in hemophiliacs. Ann Intern Med 1968;68:39-47.
Schmidt
PJ, Holland PV, Lostumbo MM, Moss KI, Sobota JT: Hemoglobinuria due
to anti-rhwl (Cw). Am J Clin Pathol 1968;49:467-471.
Holland
PV, Wallerstein RO: Delayed hemolytic transfusion reaction with acute
renal failure. JAMA 1968;204:1107-1108.
Golde
DW, McGinniss MG, Holland PV: Mechanism of the albumin agglutination
phenomenon. Vox Sang 1969;16:465-469.
Purcell
RH, Holland PV, Walsh JH, Wong DC, Morrow, AG, Chanock RM: A complement-
fixation test for measuring Australia antigen and antibody. J Infect
Dis 1969;120:383-392.
Holland
PV, Walsh JH, Morrow AG, Purcell RH: Failure of Australia antibody to
prevent posttransfusion hepatitis. Lancet II;1969: 553-555.
Gerin
JL, Purcell RH, Hoggan MD, Holland PV, Chanock RM: Biophysical properties
of Australia antigen. J Virol 1969;4:763-768.
Purcell
RH, Walsh JH, Holland PV, Morrow AG: Studies of transfusion associated
hepatitis. In: Sanders M, Shaeffer M, eds. Third International Symposium
on Medicine and Applied Virology. St. Louis: WH Green Inc, 1969:274-283.
Kueppers
F, Holland PV, Weitkamp LR: Albumin Santa Ana: A new inherited variant.
Hum Hered 1969;19:378-384.
Purcell
RH, Gerin JL, Holland PV, Cline WF, Chanock RM: Preparation and characterization
of complement-fixing hepatitis-associated antigen and antiserum. J Infect
Dis 1970;121:222-226.
Alter
HJ, Holland PV, Schmidt PJ: Hepatitis-associated antigen; to test or
not to test. Lancet II 1970;142-143.
Miller
WV, Holland PV, Sugarbaker E, Strober W, Waldmann TA: Anaphylactic reaction
to IgA; A difficult transfusion problem. Am J Clin Pathol 1970;54:618-621.
Schmidt
PJ, Holland PV: Rh null disease. In: Proceedings of the XII Congress
of the International Society of Blood Transfusion. Moscow, 1969. 1971;230-233.
Holland
PV: Therapeutic use of blood components. In: Conn H, ed. Current Therapy
1971. Philadelphia: WB Saunders, 1971;266-274.
Alter
HJ, Holland PV, Purcell RH: Counterelectrophoresis for detection of
hepatitis-associated antigen. Methodology and comparison with gel diffusion
and complement fixation. J Lab Clin Med 1971;77:1000-1010.
Golde
DW, McGinniss MH, Holland PV: Serum agglutinins to commercially prepared
albumin. Am J Clin Path 1971;55: 655-658.
Gerin
JL, Holland PV, Purcell RH: Australia antigen: large scale purification
from human serum and biochemical studies of its proteins. J Virol 1971;7:569-575.
Miller
WV, Watson LE, Holland PV, Walsh JH: Evaluation of the effectiveness
of hepatitis screening tests. Vox Sang 1971;21:1-10.
Alter
HJ, Polesky HF, Holland PV: False positive tests for hepatitis-associated
antigen in blood donors caused by antibodies to ruminant serum proteins.
J Immunol 1972;108:358-369.
Lander
JJ, Holland PV, Alter HJ, Chanock RM, Purcell RH: Antibody to hepatitis
associated antigen: Frequency and pattern of response as detected by
radioimmunoprecipitation. JAMA 1972;220(8):1070-1082.
Holland
PV: Incidence of HBsAg in blood donors. In: Vyas GN, Perkins HA, Schmid
R, eds. Hepatitis and Blood Transfusion. New York: Grune & Stratton,
1972:275-276.
Holland
PV: Gamma globulin in posttransfusion hepatitis. In: Vyas GN, Perkins
HA, Schmid R, eds. Hepatitis and Blood Transfusion. New York: Grune
& Stratton, 1972:331-333.
Holland
PV, Purcell RH, Smith H, Alter HJ: Subtyping of hepatitis antigen (HBsAg);
simplified technique using counterelectrophoresis. J Immunol 1972;109(3):420-425.
Alter
HJ, Holland PV, Schmidt PJ, Plotz PH: Gamma globulin for hepatitis Virus
B: prevention or extension? Lancet II 1972:1110-1111.
Holland
PV, Alter HJ, Purcell RH, Lander JJ, Sgouris JT, Schmidt, PJ: Hepatitis
B antigen (HBsAg) and antibody (anti-HBsAg) in cold ethanol fractions
of human plasma. Transfusion 1972;12: 363-370.
Alter
HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG, Schmidt
PJ: Posttransfusion hepatitis after exclusion of commercial and hepatitis
B antigen positive donors. Ann Intern Med 1972;77:691-699.
Dodd
RY, Holland PV, Ni LY, Smith HM, Greenwalt TJ: Hepatitis B antigen (HBsAg):
Regional variation in incidence and subtype ratio in the American Red
Cross donor population. Am J Epidemiol 1973;97:111-115.
Holland
PV, Alter HJ, Purcell RH, Walsh JH, Morrow AG, Schmidt PJ: The infectivity
of blood containing the Australia antigen. In: Prier JE, Friedman H,
eds. Australia Antigen. Baltimore: University Park Press, 1973:191-203.
Alter
HJ, Holland PV, Lander JJ, Feinstone SM, Purcell RH: The Australia antigen
and posttransfusion hepatitis. In: Prier JE, Friedman H, eds. Australia
Antigen. Baltimore: University Park Press, 1973:205-211.
Whitaker
J, Holland PV, Alter HJ, Engel WK: Idiopathic inflammatory myopathy:
failure to detect Hepatitis B antigen in serum and muscle. Arch Neurol
1973;28:410-411.
Salisbury
KW, Plotz PH, Holland PV, Steinberg AD, Peppercorn M: Serologic abnormalities
in systemic lupus erythematosus associated with viral hepatitis and
tuberculosis. Arthritis Rheum 1973;6:406-410.
Lewis
TL, Alter HJ, Chalmers TC, Holland PV, Purcell RH, Alling DW, Young
D, Frenkel LD, Lee SL, Lamson ME: A comparison of the frequency of hepatitis
B antigen and antibody in hospital and non-hospital personnel. N Engl
J Med 1973;289(13):647-651.
Purcell
RH, Wong DC, Alter HJ, Holland PV: A microtiter solid-phase radioimmunoassay
for Hepatitis B antigen. Appl Microbiol 1973;26:478-484.
Alter
HJ, Holland PV, Purcell RH, Gerin J: The Ausria test: critical evaluation
of sensitivity and specificity. Blood 1973;42:947-957.
Feinman
SV, Berris B, Wrobel DM, Sinclair JC, Alter HJ, Holland PV: Relation
of Hepatitis-B-antigen subtypes in symptom-free carriers to geographical
origin and liver abnormalities. Lancet II 1973:867-869.
Le Bouvier
GL, Bancroft WH, Holland PV: On the rare ayr phenotype of hepatitis-B
antigen. Intervirology 1973;1:505-508.
Peters
CJ, Reeves WC, Holland PV, Alter HJ: Antigenic subtypes of hepatitis
B antigen in Panama. Am J Epidemiol 1974;9:375-380.
Gold
JWM, Alter HJ, Holland PV, Gerin JL, Purcell RH: Passive hemagglutination
assay for antibody to subtypes of hepatitis B antigen. J Immunol 1974;112:1100-1106.
Aach
RD, Alter HJ, Hollinger FB, Holland PV, Lander JJ, Melnick JL, Weiler
JM: Risk of transfusing blood containing antibody to Hepatitis-B surface
antigen. Lancet II 1974:190-193.
Alter
HJ, Holland PV, Purcell RH: Viral hepatitis-Light at the end of the
tunnel. JAMA 1974;229:293-294.
Purcell
RH, Gerin JL, Almeida JB, Holland PV: Radioimmunoassay for the detection
of the core of the Dane particle and antibody to it. Intervirology 1974;2:231-243.
Kulesza
A, Mikulska B, Holland PV, Nowoslawski A: An outbreak of nonparenterally
transmitted hepatitis type B. In: Proceedings VII International Congress
Infectious Parasitic Diseases. Warsaw. 1974:155-157.
Pintera
J, Vacl J, Holland PV, Alter HJ: Some approaches to deciding HBsAg (Australia
antigen) positivity by counter immunoelectrophoresis. Blut 1974;29:165-171.
Pintera J, Vacl J, Holland PV, Alter HJ. Effectiveness of additionally incubated counterimmunoelectrophoresis screening for Hepatitis B antigen. Scripta Medica 1974;47:347-55.
Pintera
J, Vacl J, Holland PV, Alter HJ: Distribution of HBsAg subtypes among
HBsAg positive blood donors of South Moravian region. Scripta Med 1974;47:357-362.
Alter
HJ, Chalmers TC, Freeman BM, Lunceford JL, Lewis TL, Holland PV, Pizzo
PA, Plotz PH, Meyer WJ III: Health care workers positive for hepatitis
B surface antigen: Are their contacts at risk? N Engl J Med 1975;292:454-457.
Feinstone
SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV: Transfusion-associated
hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975;292:767-770.
Holland
PV, Alter HJ: The clinical significance of hepatitis B virus antigens
and antibodies. Med Clin NA 1975;59:849-855.
Gerin
JL, Faust RM, Holland PV: Biophysical characterization of the adr subtype
of hepatitis B antigen and preparation of anti-r sera in rabbits. J
Immunol 1975;115:100-105.
Holland
PV, McGinniss MH: Laboratory and clinical significance of the albumin
agglutination phenomenon. In: Sgouris JT, Rene A, eds. Proceedings of
the Workshop on Albumin. Washington DC: G.P.O. 1975:333-337.
Alter
HJ, Holland PV, Purcell RH: The emerging pattern of post- transfusion
hepatitis. Am J Med Sci 1975;270:329-334.
Holland
PV, Madalinski K: Podtypy antygenu hepatitis B. Pol Arch Med Wewn 1975;2(2):105-111.
Holland
PV: Hepatitis B antigen subtypes: history, significance and immunogenicity.
Am J Med Sci 1975;270:161-164.
Alter
HJ, Purcell RH, Holland PV, Feinstone SM, Morrow AG, Moritsugu Y: Clinical
and serological analysis of transfusion-associated hepatitis. Lancet
II 1975:838-841.
Alter
HJ, Barker LF, Holland PV: Hepatitis B immune globulin: Evaluation of
clinical trials and rationale for usage. N Engl J Med 1975;293:1093-1094.
Holland
PV, Alter HJ: Current concepts of viral hepatitis. In: Drew WL, ed.
Viral Infections:A Clinical Approach. Philadelphia: FA Davis Co, 1976;7:189-211.
Gerety
RJ, Poplack DG, Hoofnagle JH, Blaese RM, Holland PV, Barker LF: Hepatitis
B virus infection in the Wiskott-Aldrich Syndrome. J Ped 1976;88:561-564.
Gloskowska-Moraczewska
Z, Holland PV, Madalinski K, Kalinowska B: Podtypy antygenu powierzghniowego
wirusa hepatitis B wystepujace w polsce. Acta Haemat Pol VII 1976;3:189-193.
Courouce
AM, Holland PV, Muller JY, Soulier JP, eds. HBs Antigen Subtypes. Proceedings
of International Workshop on HBs Antigen Subtypes. 1976. 158 p.
Alter
HJ, Seeff LB, Kaplan PM, McAuliffe VJ, Wright EC, Gerin JL, Purcell
RH, Holland PV, Zimmerman HJ: Type B hepatitis: The infectivity of blood
positive for e antigen and DNA polymerase after accidental needlestick
exposure. N Engl J Med 1976;295: 909-913.
Koziol
DE, Alter HJ, Kirchner JP, Holland PV: The development of HBsAg-positive
hepatitis despite the prior existence of antibody to HBsAg. J Immunol
1976;117(6):2260-2262.
Vyas
GN, Roberts I, Peterson DL, Holland PV: Nonspecific test reactions for
antibodies to hepatitis B surface antigen in chronic HBsAg carriers.
J Lab Clin Med 1977;89(2):428-432.
Dienstag
JL, Feinstone SM, Purcell RH, Wong DC, Alter HJ, Holland PV: non-A,
non-B posttransfusion hepatitis. Lancet I 1977:560-562.
Madalinski
K, Holland PV, Moraczewska Z, Kalinowska B, Alter HJ: Subtypes of HBsAg
in eastern and southeastern Europe. Vox Sang 1977;32:224-229.
Holland
PV: The use of Hepatitis B immune globulin (HBIG) in the prevention
of hepatitis. Act Haemat Pol VIII 1977;2:97-102.
Alter
HJ, Purcell RH, Gerin JL, London WT, Kaplan PM, McAuliffe VJ, Wagner
J, Holland PV: Transmission of hepatitis B to chimpanzees by hepatitis
B surface antigen-positive saliva and semen. Infection and Immunity
1977;16:928-933.
Miller
WV, Busch S, Garratty G, Harris JP, Holland PV, McCullough J, Shaw JF,
Tourault MA, Widmann FK, Solomon JM: Technical Manual, AABB 1977: 7th
Ed. 390 p.
Moraczewska
Z, Madalinski K, Holland PV: Simultaneous presence in serum of HBsAg
and Anti-HBs of different specificities. Intervirology 1978;9:89-92.
Reys
LL, Purcell RH, Holland PV, Alter HJ: The relationship between hepatitis
B virus infection and hepatic cell carcinoma in Mozambique. Trop Geogr
Med 1977;29:251-256.
Whitney
RA, Ganaway JR, Allen AM, Alter HJ, Purcell RH, Holland PV: Failure
to transmit human viral hepatitis types A and B to the congenitally
athymic nude mouse. Lab Animal Sci 1978;27:1031.
Alter
HJ, Purcell RH, Holland PV, Popper H: Transmissible agent in "non-A,
non-B" hepatitis. Lancet 1 1978:459-463.
Alter
HJ, Tabor E, Meryman HT, Hoofnagle JH, Kahn RA, Holland PV, Gerety RJ,
Barker LF: Transmission of hepatitis B virus infection by transfusion
of frozen-deglycerolized red blood cells. New Engl J Med 1978;298:637-642.
Seeff
LB, Wright EC, Zimmerman HJ, Alter HJ, Dietz AA, Felsher BF, Finkelstein
JD, Garcia-Pont P, Gerin JL, Greenlee HB, Hamilton J, Holland PV: Type
B hepatitis after needle-stick exposure: prevention with hepatitis B
immune globulin. Ann of Int Med 1978;88:285-293.
Davey
RJ, Tourault MA, Holland PV: The clinical significance of anti-H in
an individual with the Oh (Bombay) phenotype. Transfusion 1978;18:738-742.
Kolins
J, Holland PV, McGinniss MH: Multiple red cell antigen loss in acute
granulocytic leukemia. Cancer 1978;42:2248-2253.
Alter
HJ, Purcell RH, Feinstone SN, Holland PV, Morrow AG: Non-A, non-B hepatitis:
A review and interim report of an ongoing prospective study. Proceedings
of Second UCSF Symposium on Viral Hepatitis. In: Vyas GN, Cohen SN,
Schmid R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press,
1978:359-369.
Holland
PV: Discussion of paper by Dr. M Goldfield: Control of posttransfusion
hepatitis. Proceedings of Second UCSF Symposium on Viral Hepatitis.
In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis. Philadelphia.
Franklin Institute Press, 1978:415-417.
Klein
HG, Alter HJ, Holland PV: Postexposure immunoglobulin prophylaxis of
hepatitis B: A comparison of two dosage schedules. Proceedings of Second
UCSF Symposium on Viral Hepatitis. In: Vyas GN, Cohen SN, Schmid R,
eds. Viral Hepatitis. Philadelphia. Franklin Institute Press, 1978:483-486.
Courouce
AM, Holland PV: Summary of Workshop A2 - HBsAg and its subtypes. Proceedings
of Second UCSF Symposium on Viral Hepatitis. In: Vyas GN, Cohen SN,
Schmid R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press,
1978:649-654.
Spiro
TE, Jaffe R, Holland PV, Alter HJ: A Study of street heroin lots for
the presence of the hepatitis-B surface antigen. Drug and Alcohol Dependence
1978;3:393-397.
Miller
LH, McGinniss MH, Holland PV, Sigmon P: The Duffy group phenotype in
American Blacks infected with plasmodium vivax in Vietnam. Amer J Trop
Med & Hygiene 1978;27:1069-1072.
Davey
RJ, Gustafson M, Holland PV: Accelerated immune red cell destruction
in the absence of serologically detectable alloantibodies. Transfusion
1980;20:348-353.
Klein
HG, Faltz LA, McIntosh CL, Applebaum FR, Deisseroth AB, Holland PV:
Surgical hypothermia in a patient with a cold agglutinin: Management
by plasma exchange. Transfusion 1980;20: 354-357.
Milich
DR, Vyas GN, Holland PV, Courouce-Pauty AM, Sampliner RE: Plasmapheresis
of hepatitis B surface antigen carriers. Acta Haemat Pol 1980;XI:73-78.
Alter
HJ, Holland PV, Purcell RH: The current status of posttransfusion hepatitis.
Pathobiology Annual 1980;10:135-156.
Holland
P, Golosova T, Szmuness W, Ketiladze E, Purcell R, Budnitskaya P, Gerety
R, Voroshieva T, Harley E, Burlev V, Alter H, Margolina A, Lubashevskaya
E: Viral hepatitis markers in Soviet and American blood donors. Transfusion
1980;20:504-510.
Holland
PV: Transmission Patterns. In: Genetics for Blood Bankers, AABB. Washington
DC. 1980;19-29.
Chandeysson
PL, Flye WM, Simpkins SS, Holland PV: Delayed hemolytic transfusion
reaction caused by anti-P1 antibody. Transfusion 1981;21:77-82.
Holland
PV, Klein HG: Effects of pheresis. International Forum. Vox Sang 1981;39:176-177.
Holland
PV: Blood transfusions: Benefits and risks. NIH publication no. 81-1949,
1981.
Madalinski
K, Holland PV, Moraczewska Z, Nowoslawski A: Preparation of monospecific
subtyping reagents for hepatitis B surface antigen (HBsAg). Mat Med
Pol 1979;11(4):311-316.
Holland
PV, Bancroft W, Zimmerman H: Post-transfusion viral hepatitis and the
TTVs. New Engl J Med 1981;304:1033-1035.
Widmann
FK, Barnes A, Case J, Garratty G, Holland PV, McCullough JJ, Nusbacher
J, Peterson EE, Steane SM, Wallace ME, Wells J: Technical Manual, AABB.
8th edition. Washington DC, 1981. 442 p.
Alter
HJ, Purcell RH, Holland PV, Alling DW, Koziol DE: Donor transaminase
(ALT) and recipient hepatitis: Impact on blood transfusion services.
JAMA 1981;246:630-634.
Coles
SM, Klein HG, Holland PV: Alloimmunization in two multi-transfused patient
populations. Transfusion 1981;21:462-466.
Holland
PV: Syphilis testing of blood donors. International Forum. Vox Sang
1981;41:185-186.
Hollinger
B, Alter HJ, Holland PV, Aach RD: Non-A, non-B posttransfusion hepatitis
in the U.S. In: Garety R, ed. Viral Hepatitis. New York: Academic Press,
1981:49-70.
Holland
PV, Alter HJ: Non-A, non-B viral hepatitis. Human Path 1981;12:1114-1122.
Holland
PV: Other adverse effects of transfusion: In: Petz LD, Swisher S, eds.
Clinical practice of blood transfusion. Livingston NY. 1981:783-803.
Gadek
JE, Klein H, Holland PV, Crystal RG et al: Replacement therapy of alphal-antitrypsin
deficiency: Reversal of protease-antiprotease imbalance within the alveolar
structures of PiZ subjects. J Clin Invest 1981;68:1158-1165.
Holland
PV: Active and passive immunoprophylaxis of hepatitis B virus infection.
Ital J Gastroenterol 1982;14:51-55.
Bove JR,
Oberman HA, Holland PV, Ishak KG, Peck C, Shorey J: Report of the ad
hoc committee on ALT testing. Transfusion 1982;22:4-5.
Holland
PV: Available means to further reduce posttransfusion hepatitis. In:
Szmuness W, Alter HJ, Maynard JE, eds. Viral Hepatitis: 1981 International
Symposium. Philadelphia: Franklin Institute Press, 1982:563-571.
Holland
PV: Non-A, non-B viral hepatitis. Ital J Gastroenterol 1982;14:111-113.
Alter
HJ, Holland PV: The 1981 International Symposium on Viral Hepatitis.
Ital J Gastroenterol 1982;14:124-126.
Davey
RJ, Holland PV: Do you think the crossmatch with donor red cells can
be omitted when the serum of a patient has been tested for the presence
of red cell alloantibodies with a cell panel? International Forum. Vox
Sang 1982;43:151-168.
Alspach
JG, Holland PV, McKeon KL: Joint physician-nurse committee ensures safe
transfer of tasks. Hospitals 1982;56:54-55.
Holland
PV: The value of ALT-GPT screening of blood donors. International Forum.
Vox Sang 1983;44:54-56.
Holland
PV: Strategies for further reduction of transfusion associated hepatitis.
In: Overby L, Dienhardt F, Dienhardt J, eds. Viral Hepatitis: Second
International Max von Pettenkofer Symposium. New York: M Dekker, 1983:235-237.
Holland
PV: Prophylaxis of viral hepatitis: Transfusion transmitted disease
and the hepatitis B vaccine. In: Verme G, Bonino F, Rizzetto M, eds.
Viral Hepatitis and Delta Infection. New York: A R Liss, 1983:357-367.
McGinniss
MH, MacLowry JD, Holland PV: Acquisition of K:1-like antigen during
terminal sepsis. Transfusion 1984;24:28-30.
Holland
PV: Costs and benefits of radioimmunoassay in the diagnosis and prophylaxis
of viral hepatitis. In: Albertini A, Ekins RP, Galen RS, eds. Cost/benefit
and predictive value of radioimmunoassay. Amsterdam: Elsevier Science
Publishers, 1984: 213-224.
Holland
PV: Strategies for active and passive prophylaxis to the hepatitis B
virus - the adult. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral
hepatitis and liver disease. Orlando: Grune and Stratton, 1984:527-532.
Alter
HJ, Holland PV: Indirect tests to detect the non-A, non-B hepatitis
carrier state. Ann Int Med 1984;101:859-861.
Holland
PV: Hepatitis B Surface Antigen and Antibody (HBsAg/ Anti-HBs). In:
Gerety RJ, ed. Hepatitis B. Orlando: Academic Press, 1985:5-25.
Carlson
J, Bryant ML, Hinrichs S, Yamamoto J, Levy N, Yee J, Higgins J, Levine
A, Holland PV, Gardner MB, Pedersen NC: AIDS serology testing in low
and high risk groups. JAMA 1985;253: 3405-3408.
Leitman
SF, Holland PV: Irradiation of blood products: Indications and guidelines.
Transfusion 1985;25:293-300.
Holland
PV, Richards CA, Teghtmeyer JR, Douville CM, Carlson JR, Hinrichs SH,
Pederson NC: Anti-HTLV-III testing of blood donors: reproducability
and confirmability of commercial test kits. Transfusion 1985;25:395-397.
Holland
PV: Transfusion-associated graft-versus-host disease: Prevention using
irradiated blood products. In: Garratty G, ed. Current concepts in transfusion
therapy. Arlington, VA: AABB, 1985:295-315.
Koziol
DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, Hudson
LM, Shoup FJ, Krakauer H, Alter HJ: Antibody to hepatitis B core antigen
as a paradoxical marker for non-A, non-B hepatitis agents in donated
blood. Ann Int Med 1986; 104:488-495.
Ward JW,
Deppe DA, Sampson S, Perkins H, Holland PV, Fernando L, Feorino PM,
Thompson P, Kleinman S, Allen JR: Risk of human immunodeficiency virus
infection from blood donors who later developed the acquired immunodeficiency
syndrome. Ann Int Med 1987;106:61-62.
Holland
PV: The human immunodeficiency virus and the spectrum of its infection:
From asymptomatic antibody positive state to acquired immunodeficiency
syndrome (AIDS). Saluggia (Vercelli): Sorin Biomedica S.p.A., 1987:1-67.
Holland
PV, Schmidt PJ, eds. Standards for blood banks and transfusion services.
12th ed. Arlington, VA:AABB, 1987:1-52.
Holland
PV: Informing the transfusion recipient: How much is enough? In: Smith
DM, Carlson KB, eds. Current scientific/ethical dilemmas in blood banking.
Arlington, VA: AABB, 1987;15-27.
Watson-Williams
EJ, Yee JL, Carlson JR, Mertens SC, Holland PV, Sinor L, Plapp FV: Solid
phase red cell adherence immunoassay for anti-HIV 1: A simple, rapid
and accurate method for donor screening. Transfusion 1988;28:184-186.
Holland
PV: Why a new standard to prevent Creutzfeldt-Jakob Disease? Editorial.
Transfusion 1988;28:293-4.
Perkins
CI, Kizer KW, Hughes MJ, Holland PV, Lloyd JC: Anti-HIV seroprevalence
in California blood and plasma donors. West J Med 1988;149:620-622.
Holland
PV: Why test autologous units? In: Maffei LM, Thurer RL, eds. Autologous
blood transfusion: Current issues. Arlington, VA:AABB, 1988:167-176.
Holland
PV: Prevention of transfusion-associated graft-versus-host disease (GVHD).
Arch Path Lab Med 1989;113:285-291.
Holland
PV: The diagnosis and management of transfusion reactions and other
adverse effects of transfusion. In Petz LD, Swisher SN, eds. Clinical
Practice of Transfusion Medicine. Second ed. New York: Churchill Livingstone,
1989:713-736.
Aoki SK,
Holland PV: Lyme disease - another transfusion risk? Transfusion 1989;29:646-650.
Holland
PV, ed. Standards for blood banks and transfusion services. 13th ed.
Arlington, VA:AABB, 1989;1-55.
Ward JW,
Bush TJ, Perkins HA, Lieb LE, Allen JR, Goldfinger D, Samson SM, Pepkowitz
SH, Fernando LP, Holland PV, Kleinman SH, Grindon AJ, Garner JL, Rutherford
GW, Holmberg SD: The natural history of transfusion-associated infection
with human immunodeficiency virus: Factors influencing the rate of progression
to disease. New Engl J Med 1989;321:947-952.
Mosley
JW, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, Holland
PV, Bancroft WH, Zimmerman HJ, Kuo G, Choo Q-L, Houghton M: Non-A, non-B
hepatitis and antibody to hepatitis C virus. JAMA 1990;263;77-78.
Samson
S, Busch M, Ward J, Garner J, Salk S, Fernando L, Holland P, Rutherford
G, Benjamin R, Perkins H: Identification of HIV-infected transfusion
recipients: The utility of cross-referencing previous donor records
with AIDS case reports. Transfusion 1990;30:214-218.
Zeldis
JB, Depner TA, Kuramoto IK, Gish RG, Holland PV: The prevalence of hepatitis
C virus antibodies among hemodialysis patients. Ann Int Med. 1990;112:958-960.
Holland
PV: Looking ahead-Trends for the 1990's. Nance SJ, ed. Transfusion Medicine
in the 1990's. Arlington, VA: American Association of Blood Banks, 1990;253-266.
Richards
C, Holland P, Kuramoto K, Douville C, Randell R: Prevalence of antibody
to hepatitis C virus in a blood donor population. Transfusion 1991;31:109-113.
Holland
PV, Nishioka K, Seidl S: Anti-HCV testing - Implications for blood donors
and transfusion recipients. In: Hollinger FB, ed. Proceedings of the
1990 International Symposium on Viral Hepatitis and Liver Disease, 1991;874-879.
Hayashi
PH, Flynn N, McCurdy SA, Kuramoto IK, Holland PV, and Zeldis JB: Prevalence
of hepatitis C virus antibodies among patients infected with human immunodeficiency
virus. J Med Virol 1991;33:177-180.
Robertson
EF, Weare JA, Randell R, Holland PV, Madsen G, and Decker RH: Characterization
of a reduction-sensitive factor from human plasma responsible for apparent
false activity in competitive assays for antibody to hepatitis B core
antigen. J Clin Microbiol 1991;29 (3):605-610.
Holland
PV: Screening of HIV in blood banks in the U.S.A. AIDS J 1991;3 (2):145-147.
Holland
PV: Looking ahead in blood banking-trends for the 1990's. In: Giornate
Medico Chirurgiche Internazionali, Edizioni Minerva Medica, Torino 1991.
Holland
PV: Blood donors with anti-HCV - true or false positive? La Trasfusione
del Sangue, 1991;36:299-304.
Randell,
RL, Holland PV: Transfusion-associated hepatitis. In: Smith DM, Dodd
RY, eds. Transfusion transmitted infections, 1991;115-131.
Paglieroni
T, Holland PV: Effects of serial plasmapheresis on serum IgA levels
in IgA-deficient blood donors with IgA suppressor T cells. Transfusion
1992;32:139-144.
Zeldis
JB, Jain S, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV,
Flynn N: Seroepidemiology of viral infections among intravenous drug
users in Northern California. West J Med 1992;156:30-35.
Kalter
SS, Heberling RL, Barry JD, Kuramoto K, Holland PV, Sazama K: Detection
of antibody to immunodeficiency viruses by dot immmunobinding assay.
J Clin Micro 1992;30:993-995.
Kotwal
GJ, Baroudy BM, Kuramoto IK, McDonald FF, Schiff GM, Holland PV, Zeldis
JB: Detection of acute hepatitis C virus infection by ELISA using a
synthetic peptide comprising a structural epitope. Proc Natl Acad Sci
USA 1992;89;4486-4489.
Aoki S,
Holland PV: The safety of blood and blood products. In: DeVita VT Jr,
Hellman S, Rosenberg SA, eds. AIDS: Etiology, Diagnosis, Treatment and
Prevention, 3rd ed. 1992;463-470.
Sazama
K, Kuramoto IK, Holland PV, Courouce A-M, Gallo D, Hanson CV: Detection
of antibodies to human immunodeficiency virus type 2 (HIV-2) in blood
donor sera using United States assay methods for anti-HIV type 1. Transfusion
1992;32:398-401.
Lee JH,
Paglieroni TG, Holland PV, Zeldis JB: Chronic hepatitis B virus infection
in an anti-HBc-nonreactive blood donor: Variant virus or defective immune
response? Hepatology 1992;16:24-30.
Wun T,
Paglieroni T, Sazama K, Holland PV: Detection of plasmapheresis-induced
platelet activation using monoclonal antibodies. Transfusion 1992;32:534-540.
Kleinman
S, Alter H, Busch M, Holland P, et al: Increased detection of HCV infected
blood donors using a multiple antigen HCV enzyme immunoassay. Transfusion
1992;32:805-813.
Busch
MP, Holland PV: Idiopathic CD4+ T-lymphocytopenia (ICL) and the safety
of blood transfusions: What do we know and what should we do? Transfusion
1992;32:800-804.
Holland
PV: Transfusion Transmitted Infectious Diseases. Florida J Med 1993;80:33-36.
Zhang
HY, Kuramoto IK, Mamish D, Sazama K, Holland PV, Zeldis JB: Hepatitis
C virus in blood samples from volunteer donors. J Clin Micro 1993;31:606-609.
Stroncek
DF, Holland PV, Bartch G, et al: Experiences of the first 493 unrelated
marrow donors in the National Marrow Donor Program (NMDP). Blood 1993;81:1940-1946.
Aoki SK,
Finegold D, Kuramoto IK, Douville C, Richards C, Randell R, Fernando
L, Holland PV, Zeldis JB: Significance of anti-HBc in blood donors as
determined by their serologic response to the hepatitis B vaccine. Transfusion
1993;33:362-367.
Aoki SK,
Holland PV, Fernando LP, Kuramoto IK, Anderson S, Sazama K, Schoening
V, Johnson P, Wilber JC, Fenner L, Alter HJ: Evidence of hepatitis in
patients transfused with blood components containing antibody to hepatitis
C. Blood 1993;82:1000-1005.
Reesink
HW, Dodd RY, Leikola J, Holland PV, Whyte G, Hewitt P, Kühnl P,
Dominka TH: How far shall we go in the predonation selection of blood
donors to safeguard patients for blood transfusion related infections?
International Forum; Vox Sang 1993;65:1-9.
Robinson
CB, Martin WR, Ratliff JL, Holland PV, Wu R, Cross CE: Elevated levels
of serum mucin-associated antigen in adult patients with cystic fibrosis.
Am Rev Respir Dis 1993;148:385-389.
Sazama
K, Holland PV: Transfusion-induced graft-versus-host disease. In: Garratty
G, ed. Immunobiology of transfusion medicine. New York, Marcel Dekker,
Inc. 1993;631-656.
Holland
PV: Blood establishments: How AABB standards are created. In: MacPherson
JL, ed. The nation's blood supply: Is absolute safety achievable? Washington
DC, CCBC 1993;7-10.
Schupper
H, Hayashi P, Scheffel J, Aceituno S, Paglieroni T, Holland PV, Zeldsi
JB: Peripheral blood mononuclear cell responses to recombinant hepatitis
C virus antigens in patients with chronic hepatitis C. Hepatology 1993;18:1055-1060.
Busch
MP, Valinsky JE, Paglieroni T, Prince HE, Crutcher GJ, Gjerset GF, Operskalski
EA, Charlebois E, Bianco C, Holland PV, Petersen LR, Hollingsworth CG,
Mosley JW: Screening of blood donors for idiopathic CD4+ T-lymphocytopenia.
Transfusion 1994;34:192-197.
Holland
PV: Overview: Diagnostic tests for viral infections transmitted by blood.
Nucl Med Biol 1994;21:407-417.
Hayashi
PH, Fernando L, Schuch MD, Koldinger R, Kelly PB, Ingram M, DeFelice
R, Marriott SE, Holland PV, Zeldis JB: Alerts, notices and case reports:
Seronegative hepatitis C virus liver failure following transplantation
of a cadaveric heart. West J of Med 1994;160:368-371.
Wun T,
Paglieroni T, Holland PV: Prolonged circulation of activated platelets
following plasmapheresis. J Clin Apheresis 1994;9:10-16.
Aoki SK,
Kuramoto IK, Anderson S, Schoening V, Rodriguez R, Fernando L, Sazama
K, Holland PV: Evidence that use of a second-generation hepatitis C
antibody assay prevents additional cases of transfusion-transmitted
hepatitis. J Vir Hepatitis 1994;1:73-77.
Holland
PV, Paglieroni T: Circannual variation in lymphocyte subsets, revisited.
Transfusion 1994;34:512-516.
Shimizu
M, Holland PV: Toward zero occurrence of post-transfusion hepatitis:
Summary of a specialty session. In: Nishioka K, Suzuki H, Mishiro S,
Oda T, eds. Viral Hepatitis and Liver Disease; 8th International Symposium
on Viral Hepatitis and Liver Disease; 1994:507-508.
Brecher
ME, Hogan JJ, Holland PV, et al: Platelet bacterial contamination and
the use of a chemiluminescence-linked univeral bacterial ribosomal RNA
gene probe. Transfusion 1994;34:750-755.
Holland
PV: Safety in the blood bank. In Nance ST, ed. Blood Supply: Risks,
perceptions and prospects for the future. Bethesda, MD: American Association
of Blood Banks, 1994;61-78.
Anderson
SC, Kuramoto IK, Holland PV, et al: Comparison of two second-generation
anti-hepatitis C virus ELISA on 21,431 US blood donor samples. J Vir
Hepatitis 1995;2:55-61.
Paglieroni
TG, Ward J, Holland PV: Changes in peripheral blood CD5 (Bla) B-cell
populations and autoantibodies following blood transfusion. Transfusion
1995;35:189-198.
Smith
EN, Holland PV, Holliman SM, Fuller MJ: Staff costs associated with
the implementation of a comprehensive compliance program in a community
blood center. Transfusion 1995;35:679-682.
Jenner
PW, Holland PV: Diagnosis and management of transfusion reactions. In:
Clinical Practice of Transfusion Medicine, 3rd Ed., Petz LD, Swisher
SN, Kleinman S, Spence RK, Strauss RG, eds. 1995;905-929.
Holland
PV. Notification and counseling of blood donors. Vox Sang 1996;70 (suppl
3):46-49.
Okamoto
H, Kobata S, Tokita H, Inoue T, Woodfield G, Holland PV, et al: A second-generation
method of genotyping hepatitis C virus by the polymerase chain reaction
with sense and antisense primers deduced from the core gene. J Virol
Methods 1996; 57:31-45.
Holland
PV: Strategies for prevention of viral hepatitis in the United States.
In: National Strategies for Viral Hepatitis and Hepatocellular Carcinoma
in Different Countries. Tanikawa K, Suzuki H, Holland PV, eds. International
Hepatology Communications 1996;5:3-9.
Holland
PV: Viral infections in the blood supply. N Engl J Med 1996;334:1734-1735.
Mast EE,
Favorov MO, Shapiro CN, Holland PV, et al: Hepatitis E virus infection
in the Americas. In: Enterically-Transmitted Hepatitis Viruses, Proceedings
of the International Symposium on Enterically-Transmitted Hepatitis
Viruses, Paris, École du Val-de-Grâce, 1995; Buisson Y,
Coursaget P, Kane M, eds., 1996; 282-293.
Holland
PV, Barrera JM, Ercilla MG, et al: Genotyping hepatitis C virus isolates
from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin
Micro, 1996;34:2372-2378.
Holland
PV: Informed consent for transfusion recipients: How much is enough?
In: Trigger Factors in Transfusion Medicine, Proceedings of the Twentieth
International Symposium on Blood Transfusion, Groningen 1995. Sibinga
CThS, Das PC, Snyder EL, eds. Kluwer Academic Publishers, 1996:17-24.
Busch
MP, Collier A, Holland, PV et al: The Viral Activation Transfusion Study
(VATS): rationale, objectives, and design overview. Transfusion 1996;36:854-859.
Fuller
MJ, Holland PV: Comprehensive reimbursement model: An alternative to
fee-for-service reimbursement by blood centers. Trans Med Reviews 1997:11:38-43.
Holland
PV, Spence RK, Lewis L: Making donated blood safer -- and less necessary.
Patient Care 1997;31:181-196.
Holland
PV: Consent for transfusion: Is it informed? Trans Med Rev 1997;11:274-285.
Holland
PV: Screening blood donors for infectious disease: Current status and
perspectives. Central European Journal of Immunology 1997;22:167-169.
Fuller
MJ, Holland PV: The 90's Paradox: QA efforts reduce total quality. Transfusion
Science, 1997;18:597-602.
Mast EE,
Kuramoto I, Schoening V, Holland PV, et al: Prevalence of and risk factors
for antibody to hepatitis E virus seroreactivity among blood donors
in Northern California. J Infect Dis 1997;176:34-40.
Holland
PV: Risk of viral hepatitis from blood: Status report. In Viral Hepatitis
and Liver Disease, Proceedings of IX Triennial International Symposium,
Rome, Italy, April 1996; Rizzetto M, Purcell RH, Gerin JL, Verme G;
Edizioni Minerva Medica 1997; 617-619.
Mast EE,
Alter MJ, Holland PV, Purcell RH: Evaluation of assays for antibody
to hepatitis E virus by a serum panel. In Viral Hepatitis and Liver
Disease, Proceedings of IX Triennial International Symposium, Rome,
Italy, April 1996; Rizzetto M, Purcell RH, Gerin JL, Verme G; Edizioni
Minerva Medica, 1997; 327-330.
Fuller
M, Holland PV: The optimist's scenario: Blood Centre opportunities currently
available in the U.S.A. In: European Transfusion Medicine, Proceedings
of the ISBT 5th Regional (4th European) Congress, Venezia, July, 1995;
U Rossi, AL Massaro, G Sciorelli, eds.; 1136-1138.
Gresens
CJ, Holland PV: Current risks of viral hepatitis from blood transfusion.
J Gastro and Hepatology 1998;13:443-449.
Kemper
M, Witt D, Madsen T, Kuramoto K, Holland PV: The effects of dilution
on the outcome of pooled plasma testing with HIV type 1 (HIV-1) RNA
genome amplification as compared to the outcome of individual-unit testing
with other HIV-1 markers. Transfusion 1998;38:469-472.
Holland
PV: Post-transfusion hepatitis: Current risks and causes. Vox Sang 1998;74
(Suppl.2):135-141.
Holland
PV: Screening blood donors for infectious disease: Current status and
perspectives. Hepatologia Polska, Advances in Hepatitis Research 1998;5(suppl.1):89-92.
Paglieroni
TG, Perez R, Katznelson S, Muto K, Chang T, Scott S, MacKenzie MR, Holland
PV: Donor cell induced CD69 expression and intracellular IL-2 and IL-4
production by peripheral blood lymphocytes isolated from kidney transplant
recipients. Human Immunology 1999;60:41-56.
Lee TH,
Paglieroni T, Ohto H, Holland PV, Busch MP: Survival of donor leukocyte
subpopulations in immunocompetent transfusion recipients: Frequent long-term
microchimerism in severe trauma patients. Blood 1999; 93:3127-3139.
Kopko
PM, Holland PV: Process improvement in transfusion medicine: One blood
center’s approach. Arch Path Lab Med 1999;123:569-575.
Kopko
PM, Holland PV: Transfusion related acute lung injury. Brit J of Haem
1999;105:322-329.
Lara PN,
Coe TL, Zhou H, Fernando L, Holland PV, Wun T: Improved survival with
plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic
uremic syndrome. Amer J Med 1999;107:573-579.
Holland
PV: Leukocyte reduction. Sacramento Medicine 2000;10-11.
Holland
PV: Risk Management in the United States. In: Proceedings of the 11th
Hokkaido Symposium on Transfusion Medicine. Ikeda H., ed. Sapporo, Japan,
1999; 73-82.
Holland
PV: Old and New Tests: Where will it end? Vox Sang 2000;78 (suppl 2):
67-70.
Brecher
ME, Holland PV, Pineda AA, Tegtmeier GE, Yomtovian R: Growth of bacteria
in inoculated platelets: implications for bacteria detection and the
extension of platelet storage. Transfusion 2000;40:1309-1312.
Gresens
CJ, Holland PV: Other reactions and alloimmunization. In: Blood Safety
and Surveillance. Linden JV, Bianco C, eds. New York: M Dekker, Inc.
2001; 71-86.
Usuda
S, Okamoto H, Tanaka T, Kidd-Ljunggren K, Holland PV, Miyakawa Y, Mayumi
M: Differentiation of hepatitis B virus genotypes D and E by ELISA using
monoclonal antibodies to epitopes on the preS2-region product. J Virol
Methods 2000;87:81-89.
Collier
AC, Kalish LA, Busch MP, Holland PV, for the Viral Activation Transfusion
Study Group: Leukocyte-reduced red blood cell transfusions in patients
with anemia and human immunodeficiency virus infection. The Viral Activation
Transfusion Study: A Randomized Controlled Trial. JAMA 2001;285:1592-1601.
Holland
PV: Measuring the volume of packed RBCs in donors. Transfusion 2001;41:309-311.
Holland
PV, Clark K: Notification and counseling of HIV-positive donors. In:
Molecular Biology in Transfusion Medicine. Hisami Ikeda, ed. Proceedings
of the 12th Hokkaido Symposium on Transfusion Medicine, Sapporo 2000,
pages 189-198.
Kopko
PM, Holland PV: Mechanisms of severe transfusion reactions. Transfus
Clin Biol 2001;8:278-281.
Kopko
PM, Fernando LP, Bonney EN, Freeman JL, Holland PV: HIV transmissions
from a window-period platelet donation. Am J Clin Path 2001;116(4):562-566.
Kopko
PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland, PV:
HLA class II antibodies in transfusion-related acute lung injury. Transfusion
2001;41:1244-1248.
Holland,
PV: Viral safety of blood transfusion – now and then. Chin J Blood
Transfusion 2001 Vol. 14 Supplement 1-4.
Gresens
CJ, Holland PV: The disappearance of transfusion-transmitted hepatitis
C virus infections in the United States. Clinics in Liver Disease: Advances
in Hepatitis C 2001;5:1105-1113.
Janatpour
K, Holland PV: Blood support for pediatric surgery. Indian J Ped 2001;68:159-165.
Kuramoto
IK, Moriya T, Schoening V, Holland PV: Fluctuation of serum HCV RNA
levels in untreated blood donors with chronic HCV infection. J Vir Hep
2002;9:36-42.
Moriya
T, Kuramoto IK, Yoshizawa H, Holland PV: Distribution of hepatitis B
virus genotypes among American blood donors determined with a preS2
epitope enzyme-linked immunosorbent assay kit. J Clin Micro 2002; 877-880.
Kopko
PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA: Transfusion-related
acute lung injury – report of a clinical look-back investigation.
JAMA 2002;287:15:1968-1971.
Kopko
PM, Holland PV: HIV as a previous emerging virus. Blood Therapies in
Medicine 2002;2:55-56.
Holland
PV: Pathogen inactivation for blood components. Proceedings: The Third
Red Cross and Red Crescent Symposium on Blood Programs in the Asian
Region. Securing Safe Blood (III) 2002; 191-194.
Corash
L, Holland PV: Inactivation of infectious pathogens. In: The Dawn of
Transfusion Medicine in the New Century, Proceedings of the 13th Hokkaido
Symposium on Transfusion Medicine, Sapporo 2001; 185-199.
Janatpour
K, Paglieroni TG, Schuller L, Foley K, Rizzardo T, Holland PV: Interpretation
of atypical patterns encountered when using a flow cytometry-based method
to detect residual leukocytes in leukoreduced red blood cell components.
Clinical Cytometry 2002; 50:254-260.
Galel
SA, Strong DM, Tegtmeier GE, Holland PV, Kuramoto IK, Kemper M, Pietrelli
L, Gallarda J: Comparative yield of HCV RNA testing in blood donors
screened by 2.0 versus 3.0 antibody assays. Transfusion 2002; 42:1507-1513.
Janatpour,
K, Holland PV: Noninfectious serious hazards of transfusion. Current
Hematology Reports 2002; 1:149-155.
Hutchinson
K, Kopko PM, Muto KN, Tuscano J, O’Donnell RT, Holland PV, Richman
C, Paglieroni TG, Wun T: Early diagnosis and successful treatment of
transfusion-associated graft-versus-host disease with autologous peripheral
stem cell transplantation. Transfusion 2002; 42:1567-1572.
Kopko
PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV: TRALI:
correlation of antigen-antibody and monocyte activation in donor-recipient
pairs. Transfusion 2003; 43:177-184.
Holland
PV: The safest unit of blood could kill you. Proceedings of the 14th
Hokkaido Symposium on Transfusion Medicine Sapporo 2002, Blood Products
in Next Generation; 52-60.
Nollet
KE, Holland PV: Toward a coalition against transfusion-associated GVHD.
Transfusion 2003;43:1655-1657.
Nollet
KE, Holland PV: Recent progress in transfusion-associated graft-vs-host
disease. Indian Journal of Hematology & Blood Transfusion 2003;
Vol XXI : Suppl 3, 114-118.
Gresens
CJ, Holland PV: Universal leukoreduction in the USA. Indian J Hem &
Blood Transfusion 2003; Suppl 3, 109-113.
Paglieroni
TG, Janatpour K, Gosselin R, Crocker V, Dwyre DM, MacKenzie MR, Holland
PV, Larkin EC: Platelet function abnormalities in qualified whole-blood
donors: effect of medication and recent food intake. Vox Sang 2004;
86: 48-53.
Janatpour
KA, Paglieroni TG, Crocker VL, DuBois D, Holland PV: Visual assessment
of hemolysis in red blood cell units and segments can be deceptive.
Transfusion 2004;44:984-989.
Utter
GH, Owings JT, Tzong-Hae L, Paglieroni, TG, Reed WF, Gosselin, RC, Holland
PV, Busch MP: Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma 2004; 57:
702-7.
Gresens
CJ, Flynn NM, Simon NF, Jensen HM, Holland PV: Transfusion (and related
secondary) transmission of hepatitis A virus. Proceedings of the 11th
International Symposium on Viral Hepatitis and Liver Disease. Editors:
AR Jilbert, EV Lgrgacic, K Vickery, CJ Burrell, YE Cossart. Australian
Centre for Hepatitis Virology; 2004: pp. 471-472.
Kleinman
S, Strong DM, Tegtmeier G, Holland PV, Gorlin J, Cousins C, Chiacchierini
RP, Pietrelli L: Hepatitis B virus (HBV) DNA screening of blood donations
in minipools with the COBAS Ampliscreen HBV test. Transfusion 2005;45:1247-1257.
Lee T-H,
Paglieroni T, Utter G, Chafets D, Gosselin RC, Reed W, Owings JT, Holland
PV, Busch MP: High-level long-term white blood cell microchimerism after
transfusion of leukoreduced blood components to patients resuscitated
after severe traumatic injury. Transfusion 2005;45:1280-1290.
Janatpour
K, Denning L, Nelson K, Betlach B, MacKenzie M, Holland P: Comparison
of X-ray vs. gamma irradiation of CPDA-1 red cells. Vox Sang 2005;89:215-219.
Utter
GH, Owings JT, Lee T-H, Paglieroni TG, Reed WF, Gosselin RC, Holland
PV, Busch MP: Microchimerism in transfused trauma patients is associated
with diminished donor-specific lymphocyte response. J Trauma 2005;58:925-932.
Comanor
L, Holland P: Hepatitis B virus blood screening: unfinished agendas.
Vox Sang 2006;91:1-12.
Janatpour
K, Holland PV: A Brief History of Blood Transfusion. Blood Banking
and Transfusion Medicine Basic Principles and Practice. Hillyer,
Silberstein, Ness, Anderson, Roback (Eds). Churchill Livingstone Elsevier
2007, Philadelphia, PA. 3-11.
McCarthy LJ, Emmett TW, Smith DS, Holland PV: Evidence-based medicine in transfusion medicine: an update. ISBT Science Series 2007;2:35-40.
Janatpour KA, Kalmin ND, Jensen HJ, Holland PV: Clinical outcomes of ABO-incompatible RBC transfusions. Am J Clin Path 2008;129:276-281.
Holland PV:
. Transfusion 2008;48:6-7.
Holland PV: Selling blood vs. donating blood. Vox Sang 2008;94:171.
Dwyre DM and Holland PV. Hepatitis viruses. in Transfusion Microbiology Eds. JJ Barbara, FM Regan, MC Contreras. Cambridge University Press, Cambridge UK 2008, 9-23.
Dwyre DM and Holland PV. Transfusion-associated graft-versus-host disease. Vox Sang 2008;95:85-93.
Jensen HM, Galante JM, Kysar PE, Tolstikov VV, Reddy KJ, Holland PV. TRALI is due to pulmonary venule damage from leucocytes with cholesterol crystal formation. Vox Sang 2010;98:130-137.
Tran S, Lewalski EA, Dwyre DM, Hagar Y, Beckett L, Janatpour KA, Holland PV. Does donating blood for the first time during a national emergency create a better commitment to donating again? Vox Sang 2010;98:e219-224.
Dwyer DM, Fernando LP, Holland PV. Hepatitis B, Hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 2011;100:92-8.
Marcin JP, Gosselin R, Holland PV. Hypercoagulability among pediatric patients with diabetic ketoacidosis: the clot thickens. Ped Crit Care Med 2013;14:325-6.
Van Ness M, Jensen H, Adamson GN, Kysar PE, Holland PV. Neutrophils contain cholesterol crystals in transfusion-related acute lung injury (TRALI). Am J Clin Pathol 2013;140:170-76.
